Replies to Post #3440 onBREAKOUTS, RUNNERS AND HOT PENNIES

Replies to #3440 on BREAKOUTS, RUNNERS AND HOT PENNIES

03/26/11 5:06 PM

VIAP March 25,2011 15-12G Filed/Website/20Mil o/s 09'

http://www.viapharmaceuticals.com/

http://www.otcmarkets.com/stock/VIAP/company-info

http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001003929&owner=include&count=40

Upcoming Events

March 30, 2011 at 11:20 PM SING
VIA Pharmaceuticals Presents at Drug Discovery World Asia 2011, Singapore: Uncovering Opportunities for New Drugs to Treat Cardiometabolic Diseases
Marina Bay Sands Hotel, Singapore

creede

05/03/11 8:32 AM

#7263 RE: Mark #3440

re SYVC -

interesting 15-12g play, imo. The company just reinstated with the NV SOS on Thursday. The A/S per the SOS is only 50MM, and the O/S looks to be less than 30MM.

4/28/11 SYVC - SYNOVICS PHARMACEUTICALS, INC. - REINSTATED

http://nvsos.gov/sosentitysearch/corpActions.aspx?lx8nvq=8qEbev8c46vcnLp8Mf%252brbw%253d%253d&CorpName=SYNOVICS+PHARMACEUTICALS%2c+INC.

Actions\Amendments
Action Type: Reinstatement
Document Number: 20110318564-91 # of Pages: 1
File Date: 4/28/2011 Effective Date:
09-10, 10-11

Action Type: Acceptance of Registered Agent
Document Number: 20110318565-02 # of Pages: 1
File Date: 4/28/2011 Effective Date:
(No notes for this action)

Quote:
--------------------------------------------------------------------------------
Financial Information

No Par Share Count: 0 Capital Amount: $ 50,000.00
Par Share Count: 50,000,000.00 Par Share Value: $ 0.001

--------------------------------------------------------------------------------

http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=8qEbev8c46vcnLp8Mf%252brbw%253d%253d

NORTH LAND

04/07/12 2:54 PM

#8402 RE: Mark #3440

Happy Easter !!!

JLPTNG

09/14/12 9:49 AM

#8541 RE: Mark #3440

$GBHL just filed 15-12G - maybe a nice opp play

Share Structure
Market Value1 $283,433 a/o Sep 13, 2012
Shares Outstanding 25,766,661 a/o Nov 15, 2011
Float 2,105,315 a/o Apr 15, 2011
Authorized Shares 250,000,000 a/o Jun 23, 2011
Par Value 0.001
Shareholders
Shareholders of Record 219 a/o Apr 15, 2010

Website: http://www.global-gbhl.com

trader53

11/12/13 8:51 PM

#8685 RE: Mark #3440

SUGO 0.0038 - a "shell company" ?
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=93575169

SUGO - On March 28, 2013, we filed a Form 15-12G

We also determined it to be
in the best long-term interest of shareholders
to resume full reporting to the SEC.

Therefore, we hereby withdraw the Form 15-12G
filed on March 28, 2013.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88479937

American Mineral Group, Inc.
to achieve first ever profitability
and be cash flow positive
within our fiscal second quarter
beginning March 1 st." -
Erwin Vahlsing, Jr., our CFO stated
http://www.youroilandgasnews.com/news_item.php?newsID=87556
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=93598771

http://stockcharts.com/h-sc/ui?s=SUGO&p=D&yr=1&mn=8&dy=0&id=p14698694610

Lucky_Charm$

02/09/14 4:26 PM

#8705 RE: Mark #3440

BSYI .0035 105 Mil A/S...-->>> Interesting info/connections

2004 15/12G Filing
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=3032051

105 Mil A/S
http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=QPKdvEiNANvkHUp4nQFFeg%253d%253d&nt7=0

Key Executives/Board Members for Biosyntech Inc
http://investing.businessweek.com/research/stocks/private/people.asp?privcapId=723015

BioSyntech, Inc. develops biotherapeutic thermogels for tissue repair and therapeutic delivery. Its lead products in development include BST-CarGel, a biodegradable gel for cartilage repair; BST-InPod for heel pain relief; BST-DermOn for chronic wound healing; BST-Ossifil for bone filling; BST-Ossifix for bone structural support; and BST-Disc for intervertebral disc restoration. The company’s products also comprise BST-Gel-based injectable products that deliver biotherapeutics to their targeted site of action; Arthro-BST, an arthroscopic device used for the non-destructive evaluation of cartilage degradation and/or repair; and Mach-1, a micromechanical testing system for evaluating the mecha...

haber

04/25/14 12:29 AM

#8711 RE: Mark #3440

SAGD filed 15-12G today. SS is a touch old but I think still accurate.

Share Structure
Market Value1 $362,876 a/o Apr 24, 2014
Shares Outstanding 403,195,362 a/o Nov 05, 2013
Float 381,422,362 a/o Nov 05, 2013
Authorized Shares 450,000,000 a/o Nov 05, 2013

Also worth noting is a relatively new CEO:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=101074103

Mr. Kugelman, age 44 is a principal in Atlanta Capital Partners for the past 10 years, providing corporate consulting in mergers, acquisitions, public relations to several publicly-traded clients. Mr. Kugelman has been in the Investment industry since 1986 and has held the National Association of Securities Dealers Series 7, 24, 63, and 66 licenses, as well as the Certified Financial Manager designation. In the past, he has worked for Thomson McKinnon, Bear Stearns, and Merrill Lynch. Mr. Kugelman graduated form Ball State University in 1986 with a Bachelor of Science degree in Business Administration.